Chapter 3

Demand Durability

The case is most sensitive to one input: whether the premium-spirits demand Pernod monetises is temporarily depressed or structurally lower. The balance of evidence points to a cyclical, affordability-driven downturn with a real structural overlay. Volumes are recovering across the industry, but the premiumisation pricing that drove the FY2022–23 boom has inverted into downtrading — at Pernod and at every peer. Demand is not disappearing; the pricing power behind the old multiple has not yet returned.

The growth the market paid for

Pernod's investment case was built on a specific claim about its market: that international premium-plus spirits — its core segment — compounded at roughly +7% a year over the decade to 2023, against +6% for total spirits and +4% for all beverage alcohol [1]. On the strength of that, management set a medium-term framework of "the upper end of +4% to +7%" organic net-sales growth [2]. A 16x EV/EBITDA multiple is a coherent price for a business growing mid-single-digits with expanding margins.

In April 2026 that framework was reset. The new through-cycle algorithm is +3% to +6% organic growth for FY2027–29 [3]. Management lowered the ceiling and the floor of its own long-run growth rate by a point. That is a small revision in isolation, but it is the company itself conceding that the mid-cycle base is lower than the one the 16x multiple was paying for.

The premiumisation engine reversed

The clearest read on temporary-versus-permanent is in how Pernod's organic growth splits between volume and price/mix. Price/mix — pricing plus the shift toward more expensive bottles — is premiumisation made visible. Volume is the count of cases sold.

Source: Pernod Ricard FY2022 [4], FY2023 [5], FY2024 [6], FY2025 [7] and H1 FY2026 [8] sales releases (Strategic International Brands).

Two distinct phases sit inside that chart. FY2022–23 was the post-pandemic boom: volumes surged +16 points in FY2022, then in FY2023 volume went flat while price/mix carried +11 points, the cyclical peak of the pricing-and-mix push [9]. FY2024 was a volume problem with premiumisation intact: volumes fell −5 points on US and China destocking, but price/mix stayed positive at +2 points [10]. Had the story ended there, "temporary" would be the easy read: destock, then re-stock.

The inflection is FY2025. Volumes recovered to flat, but price/mix turned negative for the first time in the series, at −5 points [11]; the group's overall organic net sales fell −3.0% to €10,959m [12]. Price/mix stayed negative into H1 FY2026 at −4 points, alongside a −3 volume [13]. Premiumisation did not slow; it went into reverse. The engine that carried +11 points in FY2023 is now subtracting.

Source: Pernod Ricard FY2023 [14], FY2025 [15] and Q3 FY2026 [16] sales releases.

It is the category, not the company

If this were a Pernod execution failure, its peers would be pulling ahead. They are not. The same shape — volumes holding or growing, price/mix rolling over — runs through every major premium-spirits house on its most recent results.

Sources: Pernod Ricard FY2025 release [17]; Diageo FY2025 Annual Report [18]; Brown-Forman FY2026 Annual Report [19]; Rémy Cointreau 9M FY2026 sales call [20].

Diageo, the industry's largest player, grew organic net sales +1.7% in the year to June 2025, on +0.9% volume and +0.8% price/mix — but it too flagged "consumer downtrading in South East Asia and China," and noted that "when the consumer wallet is under pressure, scotch is typically one of the most adversely impacted categories" [21] [22]. Brown-Forman ran flat organically in its year to April 2026, with volume +5% fully offset by price/mix −5% — the textbook downtrading signature [23]. Rémy Cointreau is the starkest: 9M FY2026 organic −1.9%, made of +4.5% volume against −6.4% price/mix; its cognac division sold +5.4% more volume yet took −9.7% on price/mix [24] [25].

Independent US category data carry the same reading. Per the Distilled Spirits Council's 2025 figures, US supplier sales fell 2.2% in value while volumes rose 1.9%; super-premium-and-above spirits dropped about 15% in value, and the one growth category was spirits-based ready-to-drink cocktails, up 16.4%. Consumers kept buying spirits — they traded down and shifted format. That pattern is consistent with an affordability cycle, not a walk-away from the category.

The structural overlay Pernod concedes

The downtrading is cyclical in character, but demand is not moving on price alone. In its February 2026 deck, Pernod made the affirmative case that the erosion is not structural: US beverage-alcohol servings per month were roughly stable from 2018 to 2025, bottled spirits were gaining share of total servings (from 21% to 30% of servings), household penetration of spirits held near 67%, and it presented Gen-Z consumption as rising as the cohort ages into legal purchasing — while judging GLP-1 weight-loss drugs to cause "limited disruption to spirits" [26].

That deck is the bull case, and parts of it warrant scrutiny. "Stable servings" is itself an admission that category volume is not growing — the entire +4% to +7% ambition assumed a growing base. The Gen-Z series it shows is five quarters long and volatile (33%, then a spike to 55%, back to 45%), thin evidence for a durable trend. The honest counterweight is management's own May 2026 US webcast, which is more candid than the deck. Pernod's North America CEO put US bottled spirits ex-RTD "at around minus 5% in value" year-to-date, called the pressures "primarily cyclical, but not exclusively so," and named the non-cyclical drivers directly: "health and wellness, moderation, GLP-1, and generational shifts are also having an impact on spirits consumption" [27].

That is the fair synthesis. The dominant driver of today's softness is affordability and destock — cyclical, and reversible as wallets normalise. But a structural layer is real and acknowledged by the company: moderation, GLP-1, and a generation drinking less. It is second-order today, and it works on volume more than it explains the price/mix collapse. The reason it matters is duration — a cyclical trough reprices when the cycle turns; a structural drift compounds slowly against the multiple for years.

The tentative turn

The most recent data point cuts toward cyclical. In Q3 FY2026, group organic net sales returned to +0.1%, with total volumes back to +4% growth; stripping out the US and China — the two markets still contracting, at −12% and −7% in the quarter — the rest of the world grew +5%, and cognac shipments to China resumed after the duty-free suspension lifted [28]. Volume is doing what volume does after a destock: it comes back. The unresolved half is price/mix, which was still negative through H1 and which the recovery in volumes has not yet reversed.

The distinction that decides the chapter is therefore narrower than "temporary or permanent" in the abstract. On volume, the evidence for temporary is strong: penetration is stable, peers are all seeing units recover, and Pernod's own Q3 volumes turned. On price/mix — the premiumisation that justified the old multiple — the evidence is genuinely open. If downtrading is an affordability response that unwinds as real incomes recover, price/mix returns to positive and the 16x-era earning power is intact. If consumers have permanently reset to cheaper bottles and smaller formats, mid-cycle earning power is structurally lower, and the roughly 8x multiple the market now assigns is closer to right than wrong.

What would move the read, in order of information value: group price/mix returning to positive at the next full-year result; the US value trend crossing back above zero; and whether the +3% to +6% algorithm holds or is cut again. Those are the falsifiable markers. Until price/mix turns, the reduced earning power management has already written into its own framework is the fact on the page, and the burden sits with the recovery, not the decline.